# STAT-STatin and Aspirin in Trauma

> **NCT02901067** · PHASE2 · TERMINATED · sponsor: **Denver Health and Hospital Authority** · enrollment: 43 (actual)

## Conditions studied

- Wounds and Injuries
- Venous Thromboembolism

## Interventions

- **DRUG:** Aspirin and Rosuvastatin
- **DRUG:** Placebo (for Aspirin and Rosuvastatin)

## Key facts

- **NCT ID:** NCT02901067
- **Lead sponsor:** Denver Health and Hospital Authority
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2017-02-03
- **Primary completion:** 2021-05-24
- **Final completion:** 2021-08-01
- **Target enrollment:** 43 (ACTUAL)
- **Why stopped:** COVID-19 pandemic and high proportion of patients meeting exclusion criteria.
- **Last updated:** 2023-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02901067

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02901067, "STAT-STatin and Aspirin in Trauma". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02901067. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*